MAPK3 and diabetic kidney disease: Changes in iron levels can affect the ERK1/2 pathway, which has been studied in many diseases, such as liver disease (Tangudu et al. 2019), diabetic nephropathy (Tan et al. 2022), and neurodegeneration (Bautista et al. 2016).